These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 20063457)

  • 1. The therapeutic value of addiction treatment fees.
    Duffy SQ
    Health Aff (Millwood); 2010; 29(1):222. PubMed ID: 20063457
    [No Abstract]   [Full Text] [Related]  

  • 2. Financing of substance abuse treatment for children and adolescents. Committee on Child Health Financing and Committee on Substance Abuse, American Academy of Pediatrics.
    Pediatrics; 1995 Feb; 95(2):308-10. PubMed ID: 7838656
    [No Abstract]   [Full Text] [Related]  

  • 3. Does treatment 'pay for itself'? Looking at the economic argument for addiction treatment.
    Ettner SL
    Behav Healthc; 2006 May; 26(5):32-4. PubMed ID: 16736917
    [No Abstract]   [Full Text] [Related]  

  • 4. Using health insurance claims data to analyze substance abuse charges and utilization.
    Garnick DW; Horgan CM; Hendricks AM; Comstock C
    Med Care Res Rev; 1996 Sep; 53(3):350-68. PubMed ID: 10172725
    [No Abstract]   [Full Text] [Related]  

  • 5. Public managed care and service access in outpatient substance abuse treatment units.
    Chuang E; Wells R; Alexander JA
    J Behav Health Serv Res; 2011 Oct; 38(4):444-63. PubMed ID: 21184286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managed care for substance abuse treatment: impact in Iowa.
    Rohrer JE; Rohland BM; Westermann J; Knott A; Zwick J
    Adm Policy Ment Health; 1999 Jul; 26(6):429-33. PubMed ID: 10615744
    [No Abstract]   [Full Text] [Related]  

  • 7. Moving beyond access: towards a quality-orientated substance abuse treatment system in South Africa.
    Myers B; Petersen Z; Kader R; Parry CD
    S Afr Med J; 2012 Jun; 102(8):667-8. PubMed ID: 22831942
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug treatment takes a hit. As substance abuse has surged among teens, coverage for care has been curtailed.
    Gardner J
    Mod Healthc; 1996 Oct; 26(43):66, 68, 70-2. PubMed ID: 10172795
    [No Abstract]   [Full Text] [Related]  

  • 9. Service-level costing of drug abuse treatment.
    Anderson DW; Bowland BJ; Cartwright WS; Bassin G
    J Subst Abuse Treat; 1998; 15(3):201-11. PubMed ID: 9633032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating the client costs of addiction treatment: first findings from the client drug abuse treatment cost analysis program (Client DATCAP).
    Salomé HJ; French MT; Miller M; McLellan AT
    Drug Alcohol Depend; 2003 Aug; 71(2):195-206. PubMed ID: 12927658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Michigan's substance abuse services: readiness for managed care.
    Stauffer M
    Behav Healthc Tomorrow; 1995; 4(4):57-8. PubMed ID: 10172404
    [No Abstract]   [Full Text] [Related]  

  • 12. What street people reported about service access and drug treatment.
    Freund PD; Hawkins DW
    J Health Soc Policy; 2004; 18(3):87-93. PubMed ID: 15201120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is conventional wisdom wrong? Coverage for substance abuse treatment under Medicaid managed care.
    Maglione M; Ridgely MS
    J Subst Abuse Treat; 2006 Jun; 30(4):285-90. PubMed ID: 16716842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug treatment program ownership, Medicaid acceptance, and service provision.
    McBride DC; Chriqui JF; Terry-McElrath YM; Mulatu MS
    J Subst Abuse Treat; 2012 Mar; 42(2):116-24. PubMed ID: 22154032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substance use, dependence, and service utilization among the US uninsured nonelderly population.
    Wu LT; Kouzis AC; Schlenger WE
    Am J Public Health; 2003 Dec; 93(12):2079-85. PubMed ID: 14652338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The costs of pursuing accreditation for methadone treatment sites: results from a national study.
    Zarkin GA; Dunlap LJ; Homsi G
    Eval Rev; 2006 Apr; 30(2):119-38. PubMed ID: 16492995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do more...and do it better: staff-related issues in the drug treatment field that affect the quality and effectiveness of services.
    Gustafson JS
    NIDA Res Monogr; 1991; 106():53-62. PubMed ID: 1656266
    [No Abstract]   [Full Text] [Related]  

  • 18. Socioeconomic analysis of addictions treatment.
    Langenbucher JW
    Public Health Rep; 1996; 111(2):135-7. PubMed ID: 8606910
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug addiction treatment guide released.
    Miller JL
    Am J Health Syst Pharm; 1999 Nov; 56(22):2276. PubMed ID: 10582814
    [No Abstract]   [Full Text] [Related]  

  • 20. Cost-effectiveness of substance abuse services. Implications for public policy.
    Shepard DS; Larson MJ; Hoffmann NG
    Psychiatr Clin North Am; 1999 Jun; 22(2):385-400, x. PubMed ID: 10385940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.